Trial Search Results

2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Edwards Lifesciences


  • Device: Transcatheter Tricuspid Valve Replacement




Inclusion Criteria:

   - Functional or degenerative TR moderate or greater

   - Symptomatic despite medical therapy

   - The Local Site Heart Team determines that the patient is appropriate for transcatheter
   tricuspid valve replacement

Exclusion Criteria:

   - Unsuitable anatomy

   - Previous tricuspid valve repair or replacement

   - Comorbid condition(s) that, in the opinion of the investigator, could limit the
   patient's ability to participate in the study, including compliance with follow- up
   requirements, or that could impact the scientific integrity of the study.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Research Nurse